The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...

Clinical pharmacist Dr. Christina Madison joins WIRED to answer the internet's burning questions about pharmacology and ...

Dr. Alexandra Sowa, an obesity medicine specialist and author of the new book “The Ozempic Revolution” shares the pros and cons of using GLP-1 medications for weight loss. The FDA has expanded ...

With the active ingredient tirzepatide, studies indicate this drug is even more effective for weight loss than the semaglutide drugs. The two-pronged effect of Mounjaro involves both the GLP-1 ...

It also describes the pros and cons of BMI scores and what they mean and don't mean ... a BMI plays no part in the diagnosis of the condition (although it can help set weight loss goals for someone ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause three potentially blinding eye conditions. The research identified ...

It also suppresses appetite and boosts feelings of fullness, which can then lead to reduced food intake and potential weight loss. Ozempic, Wegovy, and compounded semaglutide are once-weekly ...